<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39311348</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2035-8385</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>Neurology international</Title><ISOAbbreviation>Neurol Int</ISOAbbreviation></Journal><ArticleTitle>Cerebrovascular Reactivity Assessed by Breath-Hold Functional MRI in Patients with Neurological Post-COVID-19 Syndrome-A Pilot Study.</ArticleTitle><Pagination><StartPage>992</StartPage><EndPage>1004</EndPage><MedlinePgn>992-1004</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/neurolint16050075</ELocationID><Abstract><AbstractText>Endothelial dysfunction represents a potential pathomechanism of neurological post-COVID-19 syndrome (PCS). A recent study demonstrated reduced cerebrovascular reactivity (CVR) in patients with PCS. The aim of this pilot study was to prospectively assess CVR in patients with PCS using breath-hold functional MRI (bh-fMRI). Fourteen patients with neurological PCS and leading symptoms of fatigue/memory issues/concentration disorder (PCS<sub>fmc</sub>), 11 patients with PCS and leading symptoms of myopathy/neuropathy (PCS<sub>mn</sub>), and 17 healthy controls underwent bh-fMRI. Signal change and time to peak (TTP) were assessed globally and in seven regions of interest and compared between the subgroups using one-way ANCOVA adjusting for age, time since infection, Fazekas score, and sex. No significant differences were observed. In PCS patients, the global CVR exhibited a slight, non-significant tendency to be lower compared to healthy controls (PCS<sub>fmc</sub>: 0.78 ± 0.11%, PCS<sub>mn</sub>: 0.84 ± 0.10% and 0.87 ± 0.07%). There was a non-significant trend towards lower global TTP values in the PCS subgroups than in the control group (PCS<sub>fmc</sub>: 26.41 ± 1.39 s, PCS<sub>mn</sub>: 26.32 ± 1.36 s versus 29.52 ± 0.93 s). Endothelial dysfunction does not seem to be the sole pathomechanism of neurological symptoms in PCS. Further studies in larger cohorts are required.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zerweck</LastName><ForeName>Leonie</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-4105-5131</Identifier><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, University Hospital Tuebingen, 72076 Tuebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klose</LastName><ForeName>Uwe</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0001-5236-3450</Identifier><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, University Hospital Tuebingen, 72076 Tuebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mengel</LastName><ForeName>Annerose</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2399-3020</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Stroke, University Hospital Tuebingen, 72076 Tuebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoheisel</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Traumatology and Reconstructive Surgery, BG Trauma Center Tuebingen, 72076 Tuebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eikemeier</LastName><ForeName>Melinda</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine I, University Hospital Tuebingen, 72076 Tuebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richter</LastName><ForeName>Vivien</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-4723-1055</Identifier><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, University Hospital Tuebingen, 72076 Tuebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joos</LastName><ForeName>Natalie Sophie</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Radiology, University Hospital Tuebingen, 72076 Tuebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ernemann</LastName><ForeName>Ulrike</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, University Hospital Tuebingen, 72076 Tuebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bender</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-3205-4631</Identifier><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, University Hospital Tuebingen, 72076 Tuebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hauser</LastName><ForeName>Till-Karsten</ForeName><Initials>TK</Initials><Identifier Source="ORCID">0000-0001-7604-3419</Identifier><AffiliationInfo><Affiliation>Department of Diagnostic and Interventional Neuroradiology, University Hospital Tuebingen, 72076 Tuebingen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>TÜFF program, 2723-0-0</GrantID><Agency>Medical Faculty Tübingen (TÜFF program, 2723-0-0)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Neurol Int</MedlineTA><NlmUniqueID>101551564</NlmUniqueID><ISSNLinking>2035-8385</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">breath-hold functional MRI</Keyword><Keyword MajorTopicYN="N">cerebrovascular reactivity</Keyword><Keyword MajorTopicYN="N">post-COVID-syndrome</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39311348</ArticleId><ArticleId IdType="pmc">PMC11417792</ArticleId><ArticleId IdType="doi">10.3390/neurolint16050075</ArticleId><ArticleId IdType="pii">neurolint16050075</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102–e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallek M., Adorjan K., Behrends U., Ertl G., Suttorp N., Lehmann C. Post-COVID Syndrome. Dtsch. Arztebl. Int. 2023;120:48–55. doi: 10.3238/arztebl.m2022.0409.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2022.0409</ArticleId><ArticleId IdType="pmc">PMC10060997</ArticleId><ArticleId IdType="pubmed">36633452</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter R.S., Nieters A., Krausslich H.G., Brockmann S.O., Gopel S., Kindle G., Merle U., Steinacker J.M., Rothenbacher D., Kern W.V., et al. Post-acute sequelae of COVID-19 six to 12 months after infection: Population based study. BMJ. 2022;379:e071050. doi: 10.1136/bmj-2022-071050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071050</ArticleId><ArticleId IdType="pmc">PMC9557001</ArticleId><ArticleId IdType="pubmed">36229057</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L., Kannapadi N.V., Briggs J., Seal S.M., Battaglini D., Fanning J., Suen J., Robba C., Fraser J., Cho S.M. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J. Neurol. Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesselingh R. Prevalence, pathogenesis and spectrum of neurological symptoms in COVID-19 and post-COVID-19 syndrome: A narrative review. Med. J. Aust. 2023;219:230–236. doi: 10.5694/mja2.52063.</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/mja2.52063</ArticleId><ArticleId IdType="pubmed">37660309</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghotbi Z., Estakhr M., Hosseini M., Shahripour R.B. Cerebral Vasomotor Reactivity in COVID-19: A Narrative Review. Life. 2023;13:1614. doi: 10.3390/life13071614.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life13071614</ArticleId><ArticleId IdType="pmc">PMC10381148</ArticleId><ArticleId IdType="pubmed">37511989</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L., Laksono B.M., de Vrij F.M.S., Kushner S.A., Harschnitz O., van Riel D. The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2. Trends Neurosci. 2022;45:358–368. doi: 10.1016/j.tins.2022.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2022.02.006</ArticleId><ArticleId IdType="pmc">PMC8890977</ArticleId><ArticleId IdType="pubmed">35279295</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosselmann C.M., Kegele J., Zerweck L., Klose U., Ethofer S., Roder C., Grimm A.M., Hauser T.K. Breath-Hold-Triggered BOLD fMRI in Drug-Resistant Nonlesional Focal Epilepsy—A Pilot Study. Clin. Neuroradiol. 2023;34:315–324. doi: 10.1007/s00062-023-01363-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00062-023-01363-2</ArticleId><ArticleId IdType="pmc">PMC11130005</ArticleId><ArticleId IdType="pubmed">38082172</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Melmed K., Fang T., Granger A., Lin J., Yaghi S., Zhou T., Lewis A., Kurz S., Kahn D.E., et al. Toxic Metabolic Encephalopathy in Hospitalized Patients with COVID-19. Neurocrit Care. 2021;35:693–706. doi: 10.1007/s12028-021-01220-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-021-01220-5</ArticleId><ArticleId IdType="pmc">PMC7962078</ArticleId><ArticleId IdType="pubmed">33725290</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol. Rep. 2021;9:e14726. doi: 10.14814/phy2.14726.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14726</ArticleId><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S., Ibn Hadj Amor H., Jdidi J., Torjmen S., Kraiem S., Hammami R., Bahloul A., Kallel N., Moussa N., Touil I., et al. Long COVID 19 Syndrome: Is It Related to Microcirculation and Endothelial Dysfunction? Insights From TUN-EndCOV Study. Front. Cardiovasc. Med. 2021;8:745758. doi: 10.3389/fcvm.2021.745758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcic M., Marcic L., Marcic B., Capkun V., Vukojevic K. Cerebral Vasoreactivity Evaluated by Transcranial Color Doppler and Breath-Holding Test in Patients after SARS-CoV-2 Infection. J. Pers. Med. 2021;11:379. doi: 10.3390/jpm11050379.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11050379</ArticleId><ArticleId IdType="pmc">PMC8148160</ArticleId><ArticleId IdType="pubmed">34066352</ArticleId></ArticleIdList></Reference><Reference><Citation>Urback A.L., MacIntosh B.J., Goldstein B.I. Cerebrovascular reactivity measured by functional magnetic resonance imaging during breath-hold challenge: A systematic review. Neurosci. Biobehav. Rev. 2017;79:27–47. doi: 10.1016/j.neubiorev.2017.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2017.05.003</ArticleId><ArticleId IdType="pubmed">28487157</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirschenbaum D., Imbach L.L., Rushing E.J., Frauenknecht K.B.M., Gascho D., Ineichen B.V., Keller E., Kohler S., Lichtblau M., Reimann R.R., et al. Intracerebral endotheliitis and microbleeds are neuropathological features of COVID-19. Neuropathol. Appl. Neurobiol. 2021;47:454–459. doi: 10.1111/nan.12677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12677</ArticleId><ArticleId IdType="pmc">PMC7753688</ArticleId><ArticleId IdType="pubmed">33249605</ArticleId></ArticleIdList></Reference><Reference><Citation>Callen A.L., Tanabe J., Thaker A.A., Pollard R., Sauer B., Jones W., Pattee J., Steach B., Timpone V. Evaluation of Cerebrovascular Reactivity and Vessel-Wall Imaging in Patients With Prior COVID-19: A Prospective Case-Control MRI Study. Am. J. Roentgenol. 2022. ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.22.28267</ArticleId><ArticleId IdType="pubmed">36000667</ArticleId></ArticleIdList></Reference><Reference><Citation>Fierstra J., Sobczyk O., Battisti-Charbonney A., Mandell D.M., Poublanc J., Crawley A.P., Mikulis D.J., Duffin J., Fisher J.A. Measuring cerebrovascular reactivity: What stimulus to use? J. Physiol. 2013;591:5809–5821. doi: 10.1113/jphysiol.2013.259150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2013.259150</ArticleId><ArticleId IdType="pmc">PMC3872753</ArticleId><ArticleId IdType="pubmed">24081155</ArticleId></ArticleIdList></Reference><Reference><Citation>Zerweck L., Roder C., Hauser T.-K., Thurow J., Mengel A., Tatagiba M., Khan N., Meyer P.T., Ernemann U., Klose U. Hemodynamic evaluation of patients with Moyamoya Angiopathy: Comparison of resting-state fMRI to breath-hold fMRI and [15O]water PET. Neuroradiology. 2022;64:553–563. doi: 10.1007/s00234-021-02814-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00234-021-02814-8</ArticleId><ArticleId IdType="pmc">PMC8850258</ArticleId><ArticleId IdType="pubmed">34570251</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcic M., Marcic L., Lovric Kojundzic S., Marinovic Guic M., Marcic B., Caljkusic K. Chronic Endothelial Dysfunction after COVID-19 Infection Shown by Transcranial Color-Coded Doppler: A Cross-Sectional Study. Biomedicines. 2022;10:2550. doi: 10.3390/biomedicines10102550.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10102550</ArticleId><ArticleId IdType="pmc">PMC9599030</ArticleId><ArticleId IdType="pubmed">36289812</ArticleId></ArticleIdList></Reference><Reference><Citation>Brasil S., Taccone F.S., Wayhs S.Y., Tomazini B.M., Annoni F., Fonseca S., Bassi E., Lucena B., Nogueira R.C., De-Lima-Oliveira M., et al. Cerebral Hemodynamics and Intracranial Compliance Impairment in Critically Ill COVID-19 Patients: A Pilot Study. Brain Sci. 2021;11:874. doi: 10.3390/brainsci11070874.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11070874</ArticleId><ArticleId IdType="pmc">PMC8301789</ArticleId><ArticleId IdType="pubmed">34208937</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdo-Cuza A.A., Hall-Smith C., Suarez-Lopez J., Castellanos-Gutierrez R., Blanco-Gonzalez M.A., Machado-Martinez R., Pi-Avila J., Gomez-Peire F., Espinosa-Nodarse N., Lopez-Gonzalez J.C. Cerebral Hemodynamic Reserve Abnormalities Detected Via Transcranial Doppler Ultrasound in Recovered COVID-19 Patients. MEDICC Rev. 2022;24:28–31. doi: 10.37757/MR2022.V24.N1.3.</Citation><ArticleIdList><ArticleId IdType="doi">10.37757/MR2022.V24.N1.3</ArticleId><ArticleId IdType="pubmed">35157636</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandadeva D., Young B.E., Stephens B.Y., Grotle A.K., Skow R.J., Middleton A.J., Haseltine F.P., Fadel P.J. Blunted peripheral but not cerebral vasodilator function in young otherwise healthy adults with persistent symptoms following COVID-19. Am. J. Physiol. Heart Circ. Physiol. 2021;321:H479–H484. doi: 10.1152/ajpheart.00368.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00368.2021</ArticleId><ArticleId IdType="pmc">PMC8384473</ArticleId><ArticleId IdType="pubmed">34296966</ArticleId></ArticleIdList></Reference><Reference><Citation>Sebok M., van der Wouden F., Mader C., Pangalu A., Treyer V., Fisher J.A., Mikulis D.J., Hullner M., Regli L., Fierstra J., et al. Hemodynamic Failure Staging with Blood Oxygenation Level-Dependent Cerebrovascular Reactivity and Acetazolamide-Challenged (15O-)H2O-Positron Emission Tomography Across Individual Cerebrovascular Territories. J. Am. Heart Assoc. 2023;12:e029491. doi: 10.1161/JAHA.123.029491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.123.029491</ArticleId><ArticleId IdType="pmc">PMC10863778</ArticleId><ArticleId IdType="pubmed">38084716</ArticleId></ArticleIdList></Reference><Reference><Citation>Zerweck L., Hauser T.K., Roder C., Blazhenets G., Khan N., Ernemann U., Meyer P.T., Klose U. Evaluation of the cerebrovascular reactivity in patients with Moyamoya Angiopathy by use of breath-hold fMRI: Investigation of voxel-wise hemodynamic delay correction in comparison to [15O]water PET. Neuroradiology. 2023;65:539–550. doi: 10.1007/s00234-022-03088-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00234-022-03088-4</ArticleId><ArticleId IdType="pmc">PMC9905170</ArticleId><ArticleId IdType="pubmed">36434312</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauser T.-K., Seeger A., Bender B., Klose U., Thurow J., Ernemann U., Tatagiba M., Meyer P.T., Khan N., Roder C. Hypercapnic BOLD MRI compared to H215O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease. NeuroImage Clin. 2019;22:101713. doi: 10.1016/j.nicl.2019.101713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.101713</ArticleId><ArticleId IdType="pmc">PMC6370561</ArticleId><ArticleId IdType="pubmed">30743136</ArticleId></ArticleIdList></Reference><Reference><Citation>Zerweck L., Hauser T.-K., Roder C., Klose U. Investigation of the BOLD-Based MRI Signal Time Course During Short Breath-Hold Periods for Estimation of the Cerebrovascular Reactivity. SN Compr. Clin. Med. 2020;2:1551–1562. doi: 10.1007/s42399-020-00442-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00442-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum E., Lindner N., Andreas S., Behrends U., Scheibenbogen C., Christmann T., Horneber M., Klassen O., Geisler P., Maisel P., et al.  Müdigkeit S3-Leitlinie AWMF-Register-Nr. 053-002 DEGAM-Leitlinie Nr. 2.  [(accessed on 3 May 2023)].  Available online:  https://register.awmf.org/assets/guidelines/053-002l_S3_Muedigkeit_2023-01_01.pdf.</Citation></Reference><Reference><Citation>Nasreddine Z.S., Phillips N.A., Bédirian V., Charbonneau S., Whitehead V., Collin I., Cummings J.L., Chertkow H. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005;53:695–699. doi: 10.1111/j.1532-5415.2005.53221.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith A. Symbol Digit Modalities Test. Western Psychological Services; Los Angeles, CA, USA: 1973.</Citation></Reference><Reference><Citation>Rodewald K., Bartolovic M., Debelak R., Aschenbrenner S., Weisbrod M., Roesch-Ely D. Eine Normierungsstudie eines modifizierten Trail Making Tests im deutschsprachigen Raum. Z. Für Neuropsychol. 2012;23:37–48. doi: 10.1024/1016-264X/a000060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1024/1016-264X/a000060</ArticleId></ArticleIdList></Reference><Reference><Citation>Heuß D. Diagnostik bei Polyneuropathien, S1-Leitlinie. 2019.  [(accessed on 3 May 2023)].  Available online:  https://www.springermedizin.de/polyneuropathie/neurologie/s1-leitlinie-diagnostik-bei-polyneuropathien/16924714.</Citation></Reference><Reference><Citation>Lauria G., Bakkers M., Schmitz C., Lombardi R., Penza P., Devigili G., Smith A.G., Hsieh S.T., Mellgren S.I., Umapathi T., et al. Intraepidermal nerve fiber density at the distal leg: A worldwide normative reference study. J. Peripher. Nerv. Syst. 2010;15:202–207. doi: 10.1111/j.1529-8027.2010.00271.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1529-8027.2010.00271.x</ArticleId><ArticleId IdType="pubmed">21040142</ArticleId></ArticleIdList></Reference><Reference><Citation>Klehmet J., Beutner S., Hoffmann S., Dornauer M., Paul F., Reilmann R., Brandt A.U., Meisel A. Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy. BMC Neurol. 2019;19:118. doi: 10.1186/s12883-019-1339-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-019-1339-x</ArticleId><ArticleId IdType="pmc">PMC6556046</ArticleId><ArticleId IdType="pubmed">31176377</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei C., Yu X., Chen Y., Yang T., Li S., Li J., Chen X. Can Patients with Asymptomatic/Mild Illness and Moderate Illness COVID-19 Have White Matter Damage? Int. J. Gen. Med. 2023;16:4585–4593. doi: 10.2147/IJGM.S434968.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S434968</ArticleId><ArticleId IdType="pmc">PMC10576465</ArticleId><ArticleId IdType="pubmed">37840824</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasilev Y., Blokhin I., Khoruzhaya A., Kodenko M., Kolyshenkov V., Nanova O., Shumskaya Y., Omelyanskaya O., Vladzymyrskyy A., Reshetnikov R. Routine Brain MRI Findings on the Long-Term Effects of COVID-19: A Scoping Review. Diagnostics. 2023;13:2533. doi: 10.3390/diagnostics13152533.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13152533</ArticleId><ArticleId IdType="pmc">PMC10417725</ArticleId><ArticleId IdType="pubmed">37568896</ArticleId></ArticleIdList></Reference><Reference><Citation>Bungenberg J., Humkamp K., Hohenfeld C., Rust M.I., Ermis U., Dreher M., Hartmann N.K., Marx G., Binkofski F., Finke C., et al. Long COVID-19: Objectifying most self-reported neurological symptoms. Ann. Clin. Transl. Neurol. 2022;9:141–154. doi: 10.1002/acn3.51496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51496</ArticleId><ArticleId IdType="pmc">PMC8862437</ArticleId><ArticleId IdType="pubmed">35060361</ArticleId></ArticleIdList></Reference><Reference><Citation>Zerweck L., Roder C., Blazhenets G., Martus P., Thurow J., Haas P., Estler A., Gohla G., Ruff C., Selo N., et al. MRI-Based Assessment of Risk for Stroke in Moyamoya Angiopathy (MARS-MMA): An MRI-Based Scoring System for the Severity of Moyamoya Angiopathy. Diagnostics. 2024;14:1437. doi: 10.3390/diagnostics14131437.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics14131437</ArticleId><ArticleId IdType="pmc">PMC11241620</ArticleId><ArticleId IdType="pubmed">39001327</ArticleId></ArticleIdList></Reference><Reference><Citation>Dlamini N., Shah-Basak P., Leung J., Kirkham F., Shroff M., Kassner A., Robertson A., Dirks P., Westmacott R., deVeber G., et al. Breath-Hold Blood Oxygen Level-Dependent MRI: A Tool for the Assessment of Cerebrovascular Reserve in Children with Moyamoya Disease. AJNR Am. J. Neuroradiol. 2018;39:1717–1723. doi: 10.3174/ajnr.A5739.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A5739</ArticleId><ArticleId IdType="pmc">PMC7655282</ArticleId><ArticleId IdType="pubmed">30139753</ArticleId></ArticleIdList></Reference><Reference><Citation>Sebok M., van Niftrik C.H.B., Winklhofer S., Wegener S., Esposito G., Stippich C., Luft A., Regli L., Fierstra J. Mapping Cerebrovascular Reactivity Impairment in Patients With Symptomatic Unilateral Carotid Artery Disease. J. Am. Heart Assoc. 2021;10:e020792. doi: 10.1161/JAHA.121.020792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.020792</ArticleId><ArticleId IdType="pmc">PMC8477889</ArticleId><ArticleId IdType="pubmed">34102856</ArticleId></ArticleIdList></Reference><Reference><Citation>Sebok M., van Niftrik C.H.B., Muscas G., Pangalu A., Seystahl K., Weller M., Regli L., Fierstra J. Hypermetabolism and impaired cerebrovascular reactivity beyond the standard MRI-identified tumor border indicate diffuse glioma extended tissue infiltration. Neurooncol Adv. 2021;3:vdab048. doi: 10.1093/noajnl/vdab048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/noajnl/vdab048</ArticleId><ArticleId IdType="pmc">PMC8156976</ArticleId><ArticleId IdType="pubmed">34056603</ArticleId></ArticleIdList></Reference><Reference><Citation>Fierstra J., van Niftrik C., Warnock G., Wegener S., Piccirelli M., Pangalu A., Esposito G., Valavanis A., Buck A., Luft A., et al. Staging Hemodynamic Failure With Blood Oxygen-Level-Dependent Functional Magnetic Resonance Imaging Cerebrovascular Reactivity: A Comparison Versus Gold Standard (15O-)H2O-Positron Emission Tomography. Stroke. 2018;49:621–629. doi: 10.1161/STROKEAHA.117.020010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.020010</ArticleId><ArticleId IdType="pubmed">29371433</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobczyk O., Battisti-Charbonney A., Poublanc J., Crawley A.P., Sam K., Fierstra J., Mandell D.M., Mikulis D.J., Duffin J., Fisher J.A. Assessing cerebrovascular reactivity abnormality by comparison to a reference atlas. J. Cereb. Blood Flow. Metab. 2015;35:213–220. doi: 10.1038/jcbfm.2014.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2014.184</ArticleId><ArticleId IdType="pmc">PMC4426737</ArticleId><ArticleId IdType="pubmed">25388679</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobczyk O., Battisti-Charbonney A., Fierstra J., Mandell D.M., Poublanc J., Crawley A.P., Mikulis D.J., Duffin J., Fisher J.A. A conceptual model for CO2-induced redistribution of cerebral blood flow with experimental confirmation using BOLD MRI. Neuroimage. 2014;92:56–68. doi: 10.1016/j.neuroimage.2014.01.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2014.01.051</ArticleId><ArticleId IdType="pubmed">24508647</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennisi M., Lanza G., Falzone L., Fisicaro F., Ferri R., Bella R. SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms. Int. J. Mol. Sci. 2020;21:5475. doi: 10.3390/ijms21155475.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21155475</ArticleId><ArticleId IdType="pmc">PMC7432482</ArticleId><ArticleId IdType="pubmed">32751841</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>